The WHO classified the Nimbus variant as a Variant Under Monitoring, while CDC recommendations aligned with FDA policy guidance.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Control Data Corporation →

  defunct supercomputer firm

  • The Securities and Exchange Commission (SECP) guides the digital initiative of Control Data Corporation (CDCPL), which operates within the Pakistani market. Sidhu chaired the relevant meeting.Sun 11:40
  • Jacobs is the union president for Control Data Corporation (CDC) workers in Atlanta.Sun 02:36
• Nimbus →

  company in Turin, Italy

  Nothing else this week.

• World Health Organization →

  United Nations agency concerned with international public health

  • The U.S. ordered its withdrawal from the World Health Organization amid global health initiative impacts.Mon 11:20
  • The Ebola outbreak in the DRC is spreading to Uganda, with new cases reported in Ituri province.Mon 05:14

Related events

• The FDA aligned vaccine formulas with global health recommendations provided by the World Health Organization.Aug 29
• FDA approved new COVID booster vaccines, with major medical groups like AAP and AMA offering support and facing political pressure regarding their guidance.Sep 21
• On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.Aug 28
• Pfizer and Valneva are partnering on a Lyme vaccine and are currently seeking necessary approval from the FDA.Aug 29
• FDA granted approval for Pfizer's updated vaccine on September 2, 2025.Jun 7